Raffles Medical Group (SGX:BSL) - Aktienkurs, Nachrichten und Analyse

BSL Aktienübersicht

Die Raffles Medical Group Ltd bietet integrierte private Gesundheitsdienstleistungen hauptsächlich in Singapur, China, Vietnam, Kambodscha und Japan an. Mehr Details

BSL grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	5/6
Künftiges Wachstum	3/6
Vergangene Leistung	2/6
Finanzielle Gesundheit	6/6
Dividenden	4/6

Belohnungen

51.6% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 12.62% pro Jahr

Analysten sind sich einig, dass der Aktienkurs um 27.8%

Risikoanalyse

Die Gewinnspannen (8.7%) sind niedriger als im Vorjahr (18.3%)

Unbeständige Dividendenentwicklung

Raffles Medical Group Ltd Wettbewerber

Thomson Medical Group

SGX:A50

S$1.3b

ISEC Healthcare

Catalist:40T

S$227.2m

Econ Healthcare (Asia)

Catalist:EHG

S$57.2m

OUE Healthcare

Catalist:5WA

S$124.4m

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Raffles Medical Group
Historische Aktienkurse
Aktueller Aktienkurs	S$0.86
52-Wochen-Hoch	S$1.10
52-Wochen-Tief	S$0.85
Beta	0.54
11 Monat Veränderung	-3.37%
3 Monate Veränderung	-4.97%
1 Jahr Veränderung	-18.10%
33 Jahre Veränderung	-37.68%
5 Jahre Veränderung	-13.57%
Veränderung seit IPO	451.08%

Aktuelle Nachrichten und Updates

Recent updates

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

May 09

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Apr 25

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Nov 16

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Nov 03

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Oct 09

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Sep 26

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Sep 01

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Aug 20

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Jun 01

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

May 02

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Apr 18

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Feb 21

Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Oct 14

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Oct 02

At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Sep 21

Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Aug 12

Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

Jul 01

At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

May 25

Does This Valuation Of Raffles Medical Group Ltd (SGX:BSL) Imply Investors Are Overpaying?

Apr 05

Aktionärsrenditen

	BSL	SG Healthcare	SG Markt
7D	-1.1%	0.4%	0.5%
1Y	-18.1%	-11.7%	14.1%

Rendite im Vergleich zur Industrie: BSL unter dem Niveau der Branche SG Healthcare , die im vergangenen Jahr eine Rendite von -11.7% erzielte.

Rendite vs. Markt: BSL hinter dem Markt SG zurück, der im vergangenen Jahr eine Rendite von 14.1 erzielte.

Preisvolatilität

Is BSL's price volatile compared to industry and market?
BSL volatility
BSL Average Weekly Movement	2.0%
Healthcare Industry Average Movement	5.2%
Market Average Movement	4.6%
10% most volatile stocks in SG Market	14.4%
10% least volatile stocks in SG Market	2.1%

Stabiler Aktienkurs: BSL hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: BSLDie wöchentliche Volatilität (2%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1976	2,900	Choon Yong Loo	www.rafflesmedicalgroup.com

Die Raffles Medical Group Ltd bietet integrierte private Gesundheitsdienstleistungen hauptsächlich in Singapur, China, Vietnam, Kambodscha und Japan an. Das Unternehmen ist in den Segmenten Healthcare Services, Hospital Services, Investment Holdings und Insurance Services tätig. Das Raffles Hospital, ein Krankenhaus der Tertiärversorgung, bietet eine Reihe von medizinischen und chirurgischen Einrichtungen, darunter Tagesangiographiesäle, Operationssäle, Entbindungssäle, eine Intensivstation, eine Neugeborenen-Intensivstation, Radiologie, ein klinisches Labor und zahnärztliche Dienste.

Raffles Medical Group Ltd's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Raffles Medical Group im Vergleich zum Marktanteil des Unternehmens?
BSL grundlegende Statistiken
Marktanteil	S$1.60b
Gewinn(TTM)	S$60.94m
Umsatz(TTM)	S$702.97m

26.2x

Kurs-Gewinn-Verhältnis

2.3x

Kurs-Umsatz-Verhältnis

Ist BSL zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
BSL Gewinn- und Verlustrechnung (TTM)
Einnahmen	S$702.97m
Kosten der Einnahmen	S$392.09m
Bruttogewinn	S$310.88m
Sonstige Ausgaben	S$249.94m
Umsatz	S$60.94m

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	0.033
Bruttomarge	44.22%
Nettogewinnspanne	8.67%
Schulden/Eigenkapital-Verhältnis	7.2%

Wie hat sich BSL auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

2.8%

Aktuelle Dividendenrendite

73%

Ausschüttungsquote

BSL Aktienübersicht

Belohnungen

Risikoanalyse

Raffles Medical Group Ltd Wettbewerber

SGX:A50

S$1.3b

Catalist:40T

S$227.2m

Catalist:EHG

S$57.2m

Catalist:5WA

S$124.4m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Executive Chairman & CEO recently bought S$1.3m worth of stock

Executive Chairman & CEO recently bought S$979k worth of stock

Executive Chairman & CEO recently bought S$1.5m worth of stock

Executive Chairman & CEO recently bought S$700k worth of stock

New minor risk - Dividend sustainability

Executive Chairman & CEO recently bought S$1.3m worth of stock

Recent updates

Executive Chairman & CEO recently bought S$1.3m worth of stock

Executive Chairman & CEO recently bought S$979k worth of stock

Executive Chairman & CEO recently bought S$1.5m worth of stock

Executive Chairman & CEO recently bought S$700k worth of stock

New minor risk - Dividend sustainability

Executive Chairman & CEO recently bought S$1.3m worth of stock

First half 2024 earnings released: EPS: S$0.017 (vs S$0.032 in 1H 2023)

Executive Chairman & CEO recently bought S$1.5m worth of stock

Raffles Medical Group Ltd to Report First Half, 2024 Results on Jul 29, 2024

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

Executive Chairman & CEO recently bought S$500k worth of stock

Upcoming dividend of S$0.024 per share

Raffles Medical Group Ltd Approves One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings: EPS misses analyst expectations

Now 20% undervalued

Raffles Medical Group Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024

Price target decreased by 12% to S$1.14

Consensus EPS estimates fall by 21%

Executive Chairman & CEO recently bought S$3.6m worth of stock

Dividend of S$0.024 announced

Raffles Medical Group Ltd, Annual General Meeting, Apr 26, 2024

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Investor sentiment deteriorates as stock falls 15%

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

Raffles Medical Group Ltd Announces Resignation of Soo Yu-Han Jessica as Joint Company Secretary, Effective 8 August 2023

High number of new directors

First half 2023 earnings released: EPS: S$0.032 (vs S$0.032 in 1H 2022)

Raffles Medical Group Ltd Announces Appointment of Lu Liangjian as Non-Executive and Non-Independent Director

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Raffles Medical Group Ltd to Report First Half, 2023 Results on Jul 31, 2023

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

Upcoming dividend of S$0.038 per share at 2.6% yield

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

Full year 2022 earnings: Revenues in line with analyst expectations

Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Price target increased by 8.1% to S$1.72

Full year 2022 earnings: EPS exceeds analyst expectations

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group Ltd to Report Fiscal Year 2022 Results on Feb 27, 2023

Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Now 21% undervalued

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Now 21% undervalued

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Now 20% undervalued

Investor sentiment improved over the past week

Price target increased to S$1.52

Executive Chairman & CEO recently bought S$63k worth of stock

First half 2022 earnings released

Raffles Medical Group Ltd to Report First Half, 2022 Results on Aug 01, 2022

Now 21% undervalued after recent price drop

Erträge & Einnahmen